Canada markets close in 3 hours 38 minutes

BioXcel Therapeutics, Inc. (BTAI)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
2.5450+0.0350 (+1.39%)
As of 12:20PM EDT. Market open.
Currency in USD

Valuation Measures4

Market Cap (intraday) 92.96M
Enterprise Value 129.12M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)52.98
Price/Book (mrq)N/A
Enterprise Value/Revenue 93.56
Enterprise Value/EBITDA -0.78

Trading Information

Stock Price History

Beta (5Y Monthly) 0.39
52-Week Change 3-90.79%
S&P500 52-Week Change 325.77%
52 Week High 329.5600
52 Week Low 31.9100
50-Day Moving Average 32.8012
200-Day Moving Average 33.6454

Share Statistics

Avg Vol (3 month) 31.45M
Avg Vol (10 day) 3366.19k
Shares Outstanding 537.03M
Implied Shares Outstanding 637.03M
Float 820.19M
% Held by Insiders 124.39%
% Held by Institutions 125.87%
Shares Short (Apr 15, 2024) 42.09M
Short Ratio (Apr 15, 2024) 44.08
Short % of Float (Apr 15, 2024) 423.64%
Short % of Shares Outstanding (Apr 15, 2024) 46.83%
Shares Short (prior month Mar 15, 2024) 43.14M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-5,285.90%

Management Effectiveness

Return on Assets (ttm)-74.95%
Return on Equity (ttm)-1,766.94%

Income Statement

Revenue (ttm)1.38M
Revenue Per Share (ttm)0.05
Quarterly Revenue Growth (yoy)58.00%
Gross Profit (ttm)N/A
EBITDA -167.3M
Net Income Avi to Common (ttm)-179.05M
Diluted EPS (ttm)-6.1500
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)65.22M
Total Cash Per Share (mrq)2.13
Total Debt (mrq)101.38M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)2.65
Book Value Per Share (mrq)-1.89

Cash Flow Statement

Operating Cash Flow (ttm)-155.01M
Levered Free Cash Flow (ttm)-96.55M